<code id='B02650D0AA'></code><style id='B02650D0AA'></style>
    • <acronym id='B02650D0AA'></acronym>
      <center id='B02650D0AA'><center id='B02650D0AA'><tfoot id='B02650D0AA'></tfoot></center><abbr id='B02650D0AA'><dir id='B02650D0AA'><tfoot id='B02650D0AA'></tfoot><noframes id='B02650D0AA'>

    • <optgroup id='B02650D0AA'><strike id='B02650D0AA'><sup id='B02650D0AA'></sup></strike><code id='B02650D0AA'></code></optgroup>
        1. <b id='B02650D0AA'><label id='B02650D0AA'><select id='B02650D0AA'><dt id='B02650D0AA'><span id='B02650D0AA'></span></dt></select></label></b><u id='B02650D0AA'></u>
          <i id='B02650D0AA'><strike id='B02650D0AA'><tt id='B02650D0AA'><pre id='B02650D0AA'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:153
          Adobe

          It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

          Or is there?

          advertisement

          A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Naloxone nonprofit donates 200,000 doses after FDA approval
          Naloxone nonprofit donates 200,000 doses after FDA approval

          RiViveisthesecondnaloxoneproducttoreceiveclearancetobesoldoverthecounter.HarmReductionTherapeuticsAn

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Wegovy’s successful heart trial raises vital question about weight loss

          BloombergAlandmarkstudythatfoundtheblockbusterobesitydrugWegovyreducesthechanceofheartproblemsaddsur